Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
The third most common form of dementia is often mistaken for Alzheimer's despite different treatment needsCognitive profiles ...
Levels were found to drop gradually, from women with no signs of memory ... Supports New Blood-Based Biomarker to Detect Early Brain Changes Leading to Cognitive Impairment and Dementia Dec ...
Several recent studies have suggested HRT is a risk factor in various conditions, notably Alzheimer's - now UK boffins have ...
Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests ...
Genetic differences that contribute to how long a person will live and their risk of Alzheimer's disease have been identified ...
There is a potential link between Alzheimer's disease and the herpes simplex virus-1 (HSV-1), which is a common cause for ...